×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AXGN – axogen, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AXGN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/24
08:08 am
axgn
Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
3/24
08:00 am
axgn
Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
3/17
09:07 am
axgn
AxoGen, Inc. (NASDAQ: AXGN) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $30.00 price target on the stock.
Medium
Report
AxoGen, Inc. (NASDAQ: AXGN) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $30.00 price target on the stock.
3/5
11:36 am
axgn
AxoGen, Inc. (NASDAQ: AXGN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $24.00 price target on the stock.
Low
Report
AxoGen, Inc. (NASDAQ: AXGN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $24.00 price target on the stock.
2/26
11:58 am
axgn
AxoGen, Inc. (NASDAQ: AXGN) had its price target raised by analysts at Canaccord Genuity Group Inc. from $22.00 to $26.00. They now have a "buy" rating on the stock.
Low
Report
AxoGen, Inc. (NASDAQ: AXGN) had its price target raised by analysts at Canaccord Genuity Group Inc. from $22.00 to $26.00. They now have a "buy" rating on the stock.
2/26
02:16 am
axgn
Axogen Inc (AXGN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Market ... [Yahoo! Finance]
Low
Report
Axogen Inc (AXGN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Market ... [Yahoo! Finance]
2/25
08:04 am
axgn
Axogen, Inc. To Host Analyst & Investor Day on March 4th [Yahoo! Finance]
High
Report
Axogen, Inc. To Host Analyst & Investor Day on March 4th [Yahoo! Finance]
2/25
07:59 am
axgn
AxoGen: Q4 Earnings Snapshot [Yahoo! Finance]
High
Report
AxoGen: Q4 Earnings Snapshot [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/7
07:09 am
axgn
Form 8-K Axogen, Inc. For: Apr 07
Medium
Report
Form 8-K Axogen, Inc. For: Apr 07
3/26
04:54 pm
axgn
Form 4 Axogen, Inc. For: Mar 25 Filed by: Kemp Jens
Low
Report
Form 4 Axogen, Inc. For: Mar 25 Filed by: Kemp Jens
3/26
04:53 pm
axgn
Form 4 Axogen, Inc. For: Mar 25 Filed by: DeVinney Erick Wayne
Low
Report
Form 4 Axogen, Inc. For: Mar 25 Filed by: DeVinney Erick Wayne
3/26
04:48 pm
axgn
Form 4 Axogen, Inc. For: Mar 25 Filed by: DALE MICHAEL D
Low
Report
Form 4 Axogen, Inc. For: Mar 25 Filed by: DALE MICHAEL D
3/26
04:47 pm
axgn
Form 4 Axogen, Inc. For: Mar 25 Filed by: Began Marc A
Low
Report
Form 4 Axogen, Inc. For: Mar 25 Filed by: Began Marc A
3/19
05:24 pm
axgn
Form 4 Axogen, Inc. For: Mar 16 Filed by: DeVinney Erick Wayne
Medium
Report
Form 4 Axogen, Inc. For: Mar 16 Filed by: DeVinney Erick Wayne
3/5
06:53 pm
axgn
Form 4/A Axogen, Inc. For: Feb 22 Filed by: Kemp Jens
Low
Report
Form 4/A Axogen, Inc. For: Feb 22 Filed by: Kemp Jens
3/5
06:49 pm
axgn
Form 4 Axogen, Inc. For: Mar 04 Filed by: Kemp Jens
Low
Report
Form 4 Axogen, Inc. For: Mar 04 Filed by: Kemp Jens
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/6
AxoGen, Inc. (AXGN) CEO Karen Zaderej on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha]
14.0%
2/5 Axogen, Inc. to Present at the Leerink Partners 9th Annual Global Healthcare Conference 10.5%
8/12 Form 4 Axogen, Inc. For: Aug 09 Filed by: Zaderej Karen L. 9.2%
8/16 Form 8-K Axogen, Inc. For: Aug 14 6.8%
6/12 AxoGen, Inc (NASDAQ: AXGN) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 6.4%
12/20 Form 4 Axogen, Inc. For: Dec 18 Filed by: Freitag Gregory Gene 5.6%
8/7 AxoGen (AXGN) Investor Presentation - Slideshow [Seeking Alpha] 5.5%
11/23 Edited Transcript of AXGN earnings conference call or presentation 6-Nov-19 9:30pm GMT [Yahoo! Finance News] 5.1%
8/15 Form 4 Axogen, Inc. For: Aug 09 Filed by: Gold Mark Stephen 4.9%
2/14 Form SC 13G/A Axogen, Inc. Filed by: EW Healthcare Partners, L.P. 4.7%
2/5 Axogen, Inc. to Present at the Leerink Partners 9th Annual Global Healthcare Conference 10.5%
8/12 Form 4 Axogen, Inc. For: Aug 09 Filed by: Zaderej Karen L. 9.2%
8/16 Form 8-K Axogen, Inc. For: Aug 14 6.8%
6/12 AxoGen, Inc (NASDAQ: AXGN) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 6.4%
12/20 Form 4 Axogen, Inc. For: Dec 18 Filed by: Freitag Gregory Gene 5.6%
8/7 AxoGen (AXGN) Investor Presentation - Slideshow [Seeking Alpha] 5.5%
11/23 Edited Transcript of AXGN earnings conference call or presentation 6-Nov-19 9:30pm GMT [Yahoo! Finance News] 5.1%
8/15 Form 4 Axogen, Inc. For: Aug 09 Filed by: Gold Mark Stephen 4.9%
2/14 Form SC 13G/A Axogen, Inc. Filed by: EW Healthcare Partners, L.P. 4.7%
TOP News Decliners
8/6
AxoGen Inc (AXGN) Q2 2019 Earnings Call Transcript [The Motley Fool]
-29.2%
2/24 Axogen, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results -17.0%
1/13 Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2019 and Provides 2020 Annual Guidance -15.3%
1/3 Form 4 Axogen, Inc. For: Jan 01 Filed by: Rudelius Robert James -11.6%
3/2 Axogen, Inc. to Participate at Upcoming Investor Conferences -8.1%
5/16 Form 4 Axogen, Inc. For: May 13 Filed by: Hansen David K -7.8%
1/17 Form 4 Axogen, Inc. For: Jan 01 Filed by: Zaderej Karen L. -7.6%
4/15 Axogen, Inc. to Report First Quarter 2020 Financial Results and Host Conference Call on May 6, 2020 -6.2%
4/29 Form 4 Axogen, Inc. For: Apr 28 Filed by: DeVinney Erick Wayne -4.9%
12/4 Avance® Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade® Float -4.8%
2/24 Axogen, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results -17.0%
1/13 Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2019 and Provides 2020 Annual Guidance -15.3%
1/3 Form 4 Axogen, Inc. For: Jan 01 Filed by: Rudelius Robert James -11.6%
3/2 Axogen, Inc. to Participate at Upcoming Investor Conferences -8.1%
5/16 Form 4 Axogen, Inc. For: May 13 Filed by: Hansen David K -7.8%
1/17 Form 4 Axogen, Inc. For: Jan 01 Filed by: Zaderej Karen L. -7.6%
4/15 Axogen, Inc. to Report First Quarter 2020 Financial Results and Host Conference Call on May 6, 2020 -6.2%
4/29 Form 4 Axogen, Inc. For: Apr 28 Filed by: DeVinney Erick Wayne -4.9%
12/4 Avance® Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade® Float -4.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: